Ocean Biomedical announced that as part of the annual reconstitution of the Russell stock indexes, the Company has been included in the Russell 2000 Index and the broad-market Russell 3000 Index, which became effective on Monday, June 26, 2023.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OCEA:
- Ocean Biomedical, Inc. Joins the Russell 2000® Index
- Ocean Biomedical issued patent for bispecific cancer immunotherapy treatment
- Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces U.S. Patent Issued for Bispecific Cancer Immunotherapy Treatment With Demonstrated Killing of Tumor Cells in Lung Cancer, Brain Cancer (Glioblastoma), and Metastatic Melanoma.
- Ocean Biomedical (NASDAQ: OCEA) Extends Patent Rights for Breakthrough Idiopathic Pulmonary Fibrosis Discovery To Europe
- Ocean extends patent rights for idiopathic pulmonary fibrosis discovery